{"id":2288,"date":"2025-04-16T19:16:16","date_gmt":"2025-04-16T19:16:16","guid":{"rendered":"https:\/\/onltherapeutics.com\/test\/?page_id=2288"},"modified":"2025-07-30T16:53:37","modified_gmt":"2025-07-30T16:53:37","slug":"brian-schickedanz","status":"publish","type":"page","link":"https:\/\/onltherapeutics.com\/test\/brian-schickedanz\/","title":{"rendered":"Brian Schickedanz"},"content":{"rendered":"\n
<\/div>\n\n\n\n
\n
\n

Brian Schickedanz<\/strong>
Director, Clinical Operations<\/h3>\n<\/div>\n<\/div>\n\n\n\n
\n
\n
\"Brian<\/figure>\n<\/div>\n\n\n\n
\n

With over 20 years of clinical operations experience, Brian brings deep knowledge of clinical program management and extensive R&D cross-functional expertise through all phases of drug development. Most recently, Brian headed a clinical operations program in rare diseases as an Associate Director at Amgen, and prior to its acquisition, Horizon Therapeutics. Brian earned an M.S. from Northwestern University\u2019s Kellogg School of Biotechnology and his B.S. from Michigan State University.<\/p>\n\n\n\n

<\/div>\n\n\n\n
\n
Back to Our Team<\/a><\/div>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n
<\/div>\n","protected":false},"excerpt":{"rendered":"

Brian SchickedanzDirector, Clinical Operations With over 20 years of clinical operations experience, Brian brings deep knowledge of clinical program management and extensive R&D cross-functional expertise through all phases of drug development. Most recently, Brian headed a clinical operations program in rare diseases as an Associate Director at Amgen, and prior to its acquisition, Horizon Therapeutics. […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"blank","meta":{"ngg_post_thumbnail":0,"footnotes":""},"class_list":["post-2288","page","type-page","status-publish","hentry"],"featured_image_urls_v2":{"full":"","thumbnail":"","medium":"","medium_large":"","large":"","1536x1536":"","2048x2048":"","gform-image-choice-sm":"","gform-image-choice-md":"","gform-image-choice-lg":""},"post_excerpt_stackable_v2":"

Brian SchickedanzDirector, Clinical Operations With over 20 years of clinical operations experience, Brian brings deep knowledge of clinical program management and extensive R&D cross-functional expertise through all phases of drug development. Most recently, Brian headed a clinical operations program in rare diseases as an Associate Director at Amgen, and prior to its acquisition, Horizon Therapeutics. Brian earned an M.S. from Northwestern University\u2019s Kellogg School of Biotechnology and his B.S. from Michigan State University. Back to Our Team<\/p>\n","category_list_v2":"","author_info_v2":{"name":"theo@myriadweb.com","url":"https:\/\/onltherapeutics.com\/test\/author\/theomyriadweb-com\/"},"comments_num_v2":"0 comments","_links":{"self":[{"href":"https:\/\/onltherapeutics.com\/test\/wp-json\/wp\/v2\/pages\/2288","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/onltherapeutics.com\/test\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/onltherapeutics.com\/test\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/onltherapeutics.com\/test\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/onltherapeutics.com\/test\/wp-json\/wp\/v2\/comments?post=2288"}],"version-history":[{"count":2,"href":"https:\/\/onltherapeutics.com\/test\/wp-json\/wp\/v2\/pages\/2288\/revisions"}],"predecessor-version":[{"id":2439,"href":"https:\/\/onltherapeutics.com\/test\/wp-json\/wp\/v2\/pages\/2288\/revisions\/2439"}],"wp:attachment":[{"href":"https:\/\/onltherapeutics.com\/test\/wp-json\/wp\/v2\/media?parent=2288"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}